Following SEKISUI XenoTech’s announcement SEKISUI XenoTech Adds Monkey, Rodent Hepatocytes to Patented CryostaX Product Line, Anticipates the End of Traditionally Cryopreserved Hepatocytes, various industry publications have posted coverage, including this article in Outsourcing Pharma.
The article includes additional commentary on factors influencing SEKISUI XenoTech’s transition to CryostaX® and general growth. “We’re excited about the convenience our CryostaX hepatocytes offer for our customers. We have hepatocytes available from numerous species in many formats to fit the needs of different types of research, but the patented, unique format of CryostaX is truly a game-changer for the increased efficiency and greater utility they provide for drug development,” says Dr. Chris Bohl, Global Technical Support Manager.
Learn more about:
About the Authors
Subscribe to our Newsletter
Stay up to date with our news, events and research
Do you have a question or a request for upcoming blog content?
We love to get your feedback